Clinical Trial Data Disclosure: As EMA Pushes For Patient Level Info, What Control Will Firms Have?
Executive Summary
European Medicines Agency plans to require publication of all raw clinical trial data as of January 2014. While industry fears this policy will result in release of confidential commercial information, GSK is making patient-level data available to certain researchers.